Back to search
FDAFDA · Food and drugs·Recall number D-0198-2025

Diphenhydramine HCl 25 mg, 1000 Capsules per bottle, Akron Pharma, Manufactured for: Akron Pharma, Inc., 373 RT US 46 W Building E., Suite 117, Fairfield, NJ 07004, NDC 71399-8028-2.

Published January 22, 2025 · Recall initiated: December 12, 2024

Summary

FDA records drug Class III recall D-0198-2025, published January 22, 2025 and initiated December 12, 2024. Recalling firm: Akron Pharma, Inc.; Status: Ongoing; Reported quantity: 456 bottles; Lot: Lot: KDC0124002B Exp 09/30/2026. Class III means the product is not likely to cause adverse health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Labeling: Not Elsewhere Classified: Tablets/Capsules imprinted with wrong ID.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Akron Pharma, Inc.
Distributor
Nationwide in the US
Lot
Lot: KDC0124002B Exp 09/30/2026
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Diphenhydramine HCl 25 mg, 1000 Capsules per bottle, Akron Pharma, Manufactured for: Akron Pharma, Inc., 373 RT US 46 W Building E., Suite 117, Fairfield, NJ 07004, NDC 71399-8028-2. recalled?

Yes. FDA published recall D-0198-2025 on January 22, 2025. Reported hazard: Labeling: Not Elsewhere Classified: Tablets/Capsules imprinted with wrong ID.

What should I do if I have this product?

Voluntary: Firm initiated · Letter